SCHEMBL5188652

SCHEMBL5188652

CCCc1ccc(NC(=O)Nc2ccc(C(=O)O)cc2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 1/20 0.57
NR1H4 Q96RI1 1/20 0.57
RARB P10826 6/20 0.54
HRH3 Q9Y5N1 1/20 0.54
PLK1 P53350 1/20 0.53
ALDH1A1 P00352 2/20 0.52
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
RARA P10276 1/20 0.51
MAPT P10636 1/20 0.51
MTOR P42345 1/20 0.51
CA12 O43570 2/20 0.51
CA2 P00918 2/20 0.51
CA9 Q16790 2/20 0.51
TRPV1 Q8NER1 1/20 0.51
CA1 P00915 1/20 0.51
ABCG2 Q9UNQ0 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.50
NPC1 O15118 1/20 0.50
TP53 P04637 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22059473 0.90 RARB (0.69) RARBALDH1A1MEN1KMT2ARARA
SCHEMBL15093809 0.89 HRH3 (0.65) HRH3PLK1MEN1KMT2ACA12
SCHEMBL4122562 0.87 MAPT (0.62) HRH3PLK1ALDH1A1MEN1KMT2A
SCHEMBL4111018 0.86 TP53 (0.61) EPHX2HRH3ALDH1A1MEN1KMT2A
SCHEMBL28373605 0.86 NPC1 (0.54) RARBPLK1ALDH1A1MEN1KMT2A
SCHEMBL44017 0.86 RARB (0.69) RARBPLK1ALDH1A1MEN1KMT2A
SCHEMBL5188617 0.85 NPC1 (0.66) ALDH1A1MEN1KMT2AMAPTCA12
SCHEMBL4106216 0.84 RAB9A (0.67) HRH3MEN1KMT2AMAPTCA12
SCHEMBL4122892 0.84 MAPT (0.64) ALDH1A1MEN1KMT2AMAPTABCG2
Methyl Alcohol SCHEMBL38654374 0.84 RARB (0.67) RARBPLK1ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1804785-A2 DIARYL UREAS AS CB1 ANTAGONISTS NEUROGEN CORPORATION (US) 2007-07-11 EP disclosed
WO-2006049941-A2 DIARYL UREAS AS CB1 ANTAGONISTS NEUROGEN CORPORATION (US) 2006-05-11 WO disclosed